This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Anne Debant
Introduction
Anne Debant is a prominent inventor based in Padres le Lez, France. She has made significant contributions to the field of molecular biology, particularly through her work on TRIO proteins. Her innovative research has led to advancements in diagnostic and therapeutic applications.
Latest Patents
Anne Debant holds a patent for "Trio molecules and uses related thereto." This patent encompasses nucleic acids encoding TRIO proteins, the TRIO proteins themselves, and active portions thereof. Additionally, it includes antibodies that are immunoreactive with TRIO proteins, along with preparations of such compositions. The patent also describes diagnostic and therapeutic assays and reagents for detecting and treating disorders associated with aberrant expression or loss of TRIO proteins. Furthermore, assays are provided for identifying agents that modulate the biological function of TRIO proteins.
Career Highlights
Anne Debant is affiliated with the Dana-Farber Cancer Institute Inc., where she continues her research and development efforts. Her work has been instrumental in advancing our understanding of TRIO proteins and their implications in various disorders.
Collaborations
Throughout her career, Anne has collaborated with notable colleagues, including Michel Streuli and Carles Serra-Pages. These collaborations have enriched her research and contributed to the broader scientific community.
Conclusion
Anne Debant's innovative work in the field of molecular biology, particularly regarding TRIO proteins, showcases her dedication to advancing medical science. Her contributions through patents and collaborations highlight the importance of research in developing diagnostic and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
